188 related articles for article (PubMed ID: 34539738)
1. Hologene 5: A Phase II/III Clinical Trial of Combined Cell and Gene Therapy of Junctional Epidermolysis Bullosa.
De Rosa L; Enzo E; Zardi G; Bodemer C; Magnoni C; Schneider H; De Luca M
Front Genet; 2021; 12():705019. PubMed ID: 34539738
[TBL] [Abstract][Full Text] [Related]
2. Gentamicin induces
Lincoln V; Cogan J; Hou Y; Hirsch M; Hao M; Alexeev V; De Luca M; De Rosa L; Bauer JW; Woodley DT; Chen M
Proc Natl Acad Sci U S A; 2018 Jul; 115(28):E6536-E6545. PubMed ID: 29946029
[TBL] [Abstract][Full Text] [Related]
3. Correction of junctional epidermolysis bullosa by transplantation of genetically modified epidermal stem cells.
Mavilio F; Pellegrini G; Ferrari S; Di Nunzio F; Di Iorio E; Recchia A; Maruggi G; Ferrari G; Provasi E; Bonini C; Capurro S; Conti A; Magnoni C; Giannetti A; De Luca M
Nat Med; 2006 Dec; 12(12):1397-402. PubMed ID: 17115047
[TBL] [Abstract][Full Text] [Related]
4. CRISPR/Cas9-Mediated In Situ Correction of LAMB3 Gene in Keratinocytes Derived from a Junctional Epidermolysis Bullosa Patient.
Benati D; Miselli F; Cocchiarella F; Patrizi C; Carretero M; Baldassarri S; Ammendola V; Has C; Colloca S; Del Rio M; Larcher F; Recchia A
Mol Ther; 2018 Nov; 26(11):2592-2603. PubMed ID: 30122422
[TBL] [Abstract][Full Text] [Related]
5. Successful therapeutic transplantation of revertant skin in epidermolysis bullosa.
Gostyński A; Pasmooij AM; Jonkman MF
J Am Acad Dermatol; 2014 Jan; 70(1):98-101. PubMed ID: 24176523
[TBL] [Abstract][Full Text] [Related]
6. Toward epidermal stem cell-mediated ex vivo gene therapy of junctional epidermolysis bullosa.
Dellambra E; Pellegrini G; Guerra L; Ferrari G; Zambruno G; Mavilio F; De Luca M
Hum Gene Ther; 2000 Nov; 11(16):2283-7. PubMed ID: 11084687
[TBL] [Abstract][Full Text] [Related]
7. Molecular basis of non-lethal junctional epidermolysis bullosa: identification of a 38 basepair insertion and a splice site mutation in exon 14 of the LAMB3 gene.
Cserhalmi-Friedman PB; Baden H; Burgeson RE; Christiano AM
Exp Dermatol; 1998; 7(2-3):105-11. PubMed ID: 9583749
[TBL] [Abstract][Full Text] [Related]
8. Identification of a novel homozygous
Wang W; Guo Q; Chen J; Zhang X; Li C; Li S; Liang J; Hao C; Wang J
Front Genet; 2022; 13():965375. PubMed ID: 36246619
[No Abstract] [Full Text] [Related]
9. Aberrant splicing as potential modifier of the phenotype of junctional epidermolysis bullosa.
Mittwollen R; Wohlfart S; Park J; Grosch E; Has C; Hohenester E; Schneider H; Hammersen J
J Eur Acad Dermatol Venereol; 2020 Sep; 34(9):2127-2134. PubMed ID: 32124492
[TBL] [Abstract][Full Text] [Related]
10. Adhesive stripping to remove epidermis in junctional epidermolysis bullosa for revertant cell therapy.
Gostynski A; Deviaene FC; Pasmooij AM; Pas HH; Jonkman MF
Br J Dermatol; 2009 Aug; 161(2):444-7. PubMed ID: 19416258
[TBL] [Abstract][Full Text] [Related]
11. Phase 1/2a clinical trial of gene-corrected autologous cell therapy for recessive dystrophic epidermolysis bullosa.
Eichstadt S; Barriga M; Ponakala A; Teng C; Nguyen NT; Siprashvili Z; Nazaroff J; Gorell ES; Chiou AS; Taylor L; Khuu P; Keene DR; Rieger K; Khosla RK; Furukawa LK; Lorenz HP; Marinkovich MP; Tang JY
JCI Insight; 2019 Oct; 4(19):. PubMed ID: 31578311
[TBL] [Abstract][Full Text] [Related]
12. PDigenic Mutations in Junctional Epidermolysis Bullosa in An Iranian Family.
Riahi K; Ghanbari Mardasi F; Talebi F; Jasemi F; Mohammadi Asl J
Cell J; 2021 Oct; 23(5):598-602. PubMed ID: 34837689
[TBL] [Abstract][Full Text] [Related]
13. Herlitz junctional epidermolysis bullosa.
Laimer M; Lanschuetzer CM; Diem A; Bauer JW
Dermatol Clin; 2010 Jan; 28(1):55-60. PubMed ID: 19945616
[TBL] [Abstract][Full Text] [Related]
14. Corrective transduction of human epidermal stem cells in laminin-5-dependent junctional epidermolysis bullosa.
Dellambra E; Vailly J; Pellegrini G; Bondanza S; Golisano O; Macchia C; Zambruno G; Meneguzzi G; De Luca M
Hum Gene Ther; 1998 Jun; 9(9):1359-70. PubMed ID: 9650620
[TBL] [Abstract][Full Text] [Related]
15. Predominance of the recurrent mutation R635X in the LAMB3 gene in European patients with Herlitz junctional epidermolysis bullosa has implications for mutation detection strategy.
Pulkkinen L; Meneguzzi G; McGrath JA; Xu Y; Blanchet-Bardon C; Ortonne JP; Christiano AM; Uitto J
J Invest Dermatol; 1997 Aug; 109(2):232-7. PubMed ID: 9242513
[TBL] [Abstract][Full Text] [Related]
16. Gentamicin Induces Laminin 332 and Improves Wound Healing in Junctional Epidermolysis Bullosa Patients with Nonsense Mutations.
Kwong A; Cogan J; Hou Y; Antaya R; Hao M; Kim G; Lincoln V; Chen Q; Woodley DT; Chen M
Mol Ther; 2020 May; 28(5):1327-1338. PubMed ID: 32222156
[TBL] [Abstract][Full Text] [Related]
17. A Novel Phenotype of Junctional Epidermolysis Bullosa with Transient Skin Fragility and Predominant Ocular Involvement Responsive to Human Amniotic Membrane Eyedrops.
Castiglia D; Fortugno P; Condorelli AG; Barresi S; De Luca N; Pizzi S; Neri I; Graziano C; Trojan D; Ponzin D; Rossi S; Zambruno G; Tartaglia M
Genes (Basel); 2021 May; 12(5):. PubMed ID: 34064633
[TBL] [Abstract][Full Text] [Related]
18. Towards a gene therapy clinical trial for epidermolysis bullosa.
Ferrari S; Pellegrini G; Matsui T; Mavilio F; De Luca M
Rev Recent Clin Trials; 2006 May; 1(2):155-62. PubMed ID: 18473966
[TBL] [Abstract][Full Text] [Related]
19. Application of whole exome sequencing in elucidating the phenotype and genotype spectrum of junctional epidermolysis bullosa: A preliminary experience of a tertiary care centre in India.
Yenamandra VK; Vellarikkal SK; Kumar M; Chowdhury MR; Jayarajan R; Verma A; Scaria V; Sivasubbu S; Ray SB; Dinda AK; Kabra M; Kaur P; Sharma VK; Sethuraman G
J Dermatol Sci; 2017 Apr; 86(1):30-36. PubMed ID: 28087116
[TBL] [Abstract][Full Text] [Related]
20. BP180 gene delivery in junctional epidermolysis bullosa.
Seitz CS; Giudice GJ; Balding SD; Marinkovich MP; Khavari PA
Gene Ther; 1999 Jan; 6(1):42-7. PubMed ID: 10341874
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
